Influence of non‐surgical periodontal therapy on inflammasome biomarkers in periodontitis with and without diabetes mellitus

Radhika Bhikamji Rathi, Rajashri Abhay Kolte, Abhay Pandurang Kolte, Dharmarajan Gopalakrishnan, Madhur Gupta, Prachi Rathi, Vidya Viswanathan
Journal of Periodontology · Wiley · 2026-11-18 · DOI: 10.1002/jper.70233

Аннотация

Abstract Background Periodontitis and type 2 diabetes mellitus (T2DM) are chronic inflammatory conditions linked through common pathogenic processes. Interleukin‐18 (IL‐18), absent in melanoma 2 (AIM2), and interferon gamma‐inducible protein 16 (IFI16) have been associated with inflammatory pathways of both diseases. Limited data exist regarding the effect of non‐surgical periodontal therapy (NSPT) on these biomarkers. This study was designed to evaluate and compare the effect of NSPT on serum levels of AIM2, IFI16, and IL‐18 in stage III periodontitis patients with and without T2DM. Methods Ninety participants were allocated into three groups: periodontally healthy controls (group I), stage III periodontitis (group II), stage III periodontitis with T2DM (group III). The plaque index (PI), gingival index (GI), papillary bleeding index (PBI), probing pocket depth (PPD), clinical attachment level (CAL), gingival recession (GR), periodontal inflamed surface area (PISA), periodontal epithelial surface area (PESA), random blood sugar (RBS), HbA1c, AIM2, IFI16, and IL‐18 were assessed at baseline in group I and also at 6 weeks in groups II and III. Results Serum AIM2, IFI16, and IL‐18 levels were significantly elevated in periodontitis patients, with the highest concentrations observed in group III, followed by group II at baseline. NSPT significantly improved PPD, CAL, PISA, PESA, and glycemic status; serum biomarker levels were observed in both treatment groups with greater improvements observed in group III. Conclusion Serum AIM2, IFI16, and IL‐18 levels increased progressively from group I to group III and decreased significantly following NSPT, reflecting reduced periodontal and systemic inflammation. These biomarkers may serve as potential indicators linking periodontal inflammation with metabolic dysregulation in T2DM. Trial Registration The trial was registered with the Clinical Trials Registry‐India (CTRI/2024/06/068456). Plain language summary Periodontitis and type 2 diabetes are closely linked because both are associated with inflammation. This study examined whether treating severe periodontitis without surgery could improve gum health and reduce inflammation in the body. Ninety participants, including healthy individuals and patients with periodontitis with or without diabetes, were evaluated before and after treatment. Patients with both periodontitis and diabetes had the highest levels of inflammation‐related blood markers. Following treatment, periodontal health, blood sugar, and these blood markers improved, with the greatest benefits observed in patients with diabetes. These findings suggest that periodontal treatment may improve both oral and overall health. Non‐surgical periodontal therapy improved periodontal health and reduced inflammatory blood biomarkers in patients with stage III periodontitis, with greater improvements in those with type 2 diabetes.

Читать у издателя →

Похожие статьи